Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for Cypress Bioscience Inc. > News item |
Cypress Bioscience kept by Jefferies at buy
Cypress Bioscience Inc. was maintained by Jefferies & Co. analyst Adam Walsh at a buy rating with a price target on the stock of $17 per share following second-quarter results. Cypress Bioscience shares Wednesday were unchanged at $12.95 on volume of 620,664 shares versus the three-month running average of 232,686 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.